Weekly Dose of GenAI Adoption

• Weekly Dose of GenAI Adoption - Episode 79

  The source consists of excerpts from the Weekly Dose of GenAI Adoption newsletter, authored by Indy Sawhney, a Generative AI Strategy and Adoption Leader at AWS who specializes in healthcare and life sciences. The primary focus is on accelerating GenAI adoption, particularly through Low-Code/No-Code (LCNC) agentic platforms that empower business users to redesign core workflows. These platforms are presented as a modern echo of a 1984 Canon "user innovation" experiment, shifting the power of workflow transformation away from centralized IT to frontline domain experts. The text details the strengths and limitations of LCNC agentic AI, providing a CxO Playbook for enabling governed citizen GenAI at scale through strategic selection, enablement, and integration criteria. Ultimately, the newsletter advocates for starting with simple automations to build organizational "workflow muscle," proving value quickly under IT governance before tackling complex, mission-critical processes.

  --------  

  6:36

  --------

  6:36
• Weekly Dose of GenAI Adoption - Episode 78

  The sources consist of excerpts from the Weekly Dose of GenAI Adoption newsletter, edition 78, written by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS who advises the biopharma and biotech sectors. This newsletter focuses on providing enterprise leaders with actionable insights for accelerating the adoption of Generative AI (GenAI). The central theme is the rapidly widening AI maturity divide between organizations, emphasizing that successful adoption requires organizational discipline, cultural alignment, and relentless execution, rather than simply chasing new technology. The text uses the historical Aetna turnaround as an analogy to illustrate how internal focus and disciplined execution lead to success, applying this lesson to the current challenge of integrating Agentic AI and embracing an "outcome-as-a-service" business model through strategic partnerships.

  --------  

  5:47

  --------

  5:47
• Weekly Dose of GenAI Adoption - Episode 77

  The source material, an excerpt from the "Weekly Dose of GenAI Adoption" newsletter written by Indy Sawhney, cautions enterprise leaders against viewing the adoption of agentic AI as a simple purchase, or an "Add to cart" solution. Sawhney, a Generative AI Strategy & Adoption Leader at AWS, explains that agentic AI is a complex, autonomous system that requires robust systems engineering, including orchestration, observability, compliance, and rigorous cost control. The author advises that buying pre-vetted solutions from a trusted ISV marketplace is less risky, but organizations choosing to build or deploy custom agents must be prepared to own the entire systems engineering lift and associated enterprise risks. The newsletter, which often focuses on the healthcare and life sciences industries, provides a practical CxO Playbook and a list of key questions leaders should ask before initiating any agentic AI deployment to ensure successful operationalization.

  --------  

  5:23

  --------

  5:23
• Weekly Dose of GenAI Adoption - Episode 76

  The source material, an excerpt from the "Weekly Dose of GenAI Adoption" newsletter by Indy Sawhney, discusses the challenges and strategies for accelerating the adoption of Agentic AI within the healthcare industry. It emphasizes that achieving the Healthcare Quadruple Aim—better patient experience, population health, lower costs, and care team well-being—requires more than just technology; it demands a convergence of leadership alignment, updated regulations, and cross-industry collaboration. The text draws a parallel to the successful, decade-long Straight-Through Processing (STP) transformation on Wall Street, which succeeded through pooled resources and standardized practices pushed by consortia. The author, a Generative AI Strategy & Adoption Leader at AWS, provides a "Pragmatic CxO Playbook" advocating for scaling proven solutions, prioritizing measurable Return on Investment (ROI), and moving beyond isolated pilot projects.

  --------  

  5:24

  --------

  5:24
• Weekly Dose of GenAI Adoption - Episode 75

  This newsletter, authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, focuses on practical approaches for enterprises to achieve significant ROI with GenAI. It highlights that while most GenAI pilots fail to demonstrate return on investment, successful implementations leverage "Agentic AI" to reengineer core workflows, rather than simply adding new tools. The source draws a parallel to Wall Street's "straight-through processing" (STP) as a historical example of end-to-end automation driving growth and increased margins. Sawhney provides a CxO Playbook with actionable steps for leaders to start small, experiment, and scale Agentic AI adoption effectively, emphasizing measured results over widespread, unfocused pilots. The overarching message is to strategically apply GenAI to transform operations for improved profitability and market strength.

  --------  

  5:18

  --------

  5:18

Plus de podcasts Technologies

Podcasts tendance de Technologies

À propos de Weekly Dose of GenAI Adoption